187 related articles for article (PubMed ID: 29882970)
1. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
Wang M; Smith JS; Wei WQ
Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
[TBL] [Abstract][Full Text] [Related]
3. ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction.
Shang L; Hao JJ; Zhao XK; He JZ; Shi ZZ; Liu HJ; Wu LF; Jiang YY; Shi F; Yang H; Zhang Y; Liu YZ; Zhang TT; Xu X; Cai Y; Jia XM; Li M; Zhan QM; Li EM; Wang LD; Wei WQ; Wang MR
Oncotarget; 2016 Apr; 7(17):24374-82. PubMed ID: 27016410
[TBL] [Abstract][Full Text] [Related]
4. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
5. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
6. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
7.
Baba H; Kanda M; Sawaki K; Shimizu D; Umeda S; Koike M; Kodera Y; Fujii T
Anticancer Res; 2019 Nov; 39(11):5943-5951. PubMed ID: 31704819
[TBL] [Abstract][Full Text] [Related]
8. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma.
Alaei S; Sadeghi B; Najafi A; Masoudi-Nejad A
Genomics; 2019 Jan; 111(1):76-89. PubMed ID: 29317304
[TBL] [Abstract][Full Text] [Related]
9. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma.
Gao Y; Li M; Wang B; Ma Y
Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
12. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
13. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
14.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
15. Clinical and translational advances in esophageal squamous cell carcinoma.
Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
[TBL] [Abstract][Full Text] [Related]
16. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC.
Wang Q; Liu H; Liu Z; Yang L; Zhou J; Cao X; Sun H
Cancer Genet; 2020 Jan; 240():33-39. PubMed ID: 31726270
[TBL] [Abstract][Full Text] [Related]
17. Identification of PA28β as a potential novel biomarker in human esophageal squamous cell carcinoma.
Chen JY; Xu L; Fang WM; Han JY; Wang K; Zhu KS
Tumour Biol; 2017 Oct; 39(10):1010428317719780. PubMed ID: 29020885
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis.
Wang X; Lai M; Wang Y; Chai R; Li N; Ou L; Zheng K; Li J; Xu G; Wang S; Dong Y; Wang S
Biomed Res Int; 2022; 2022():3758731. PubMed ID: 35496042
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
